Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$2.3 - $3.72 $34,960 - $56,544
-15,200 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$1.27 - $2.33 $889 - $1,631
700 Added 4.83%
15,200 $21,000
Q4 2019

Feb 11, 2020

BUY
$1.3 - $2.72 $18,850 - $39,440
14,500 New
14,500 $29,000
Q2 2019

Aug 12, 2019

SELL
$2.05 - $4.32 $186,959 - $393,984
-91,200 Closed
0 $0
Q1 2019

May 07, 2019

SELL
$1.79 - $3.12 $168,797 - $294,216
-94,300 Reduced 50.84%
91,200 $191,000
Q4 2018

Feb 12, 2019

SELL
$2.24 - $3.9 $25,760 - $44,850
-11,500 Reduced 5.84%
185,500 $476,000
Q3 2018

Nov 13, 2018

BUY
$3.58 - $4.9 $15,036 - $20,580
4,200 Added 2.18%
197,000 $766,000
Q2 2018

Aug 08, 2018

BUY
$4.43 - $5.14 $854,104 - $990,991
192,800 New
192,800 $917,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $293M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.